Gabapentin
- Product NDC
- 60687-591
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA090858
- Marketing category
- ANDA
- Substance
- GABAPENTIN
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 60687-591-01 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-591-01) / 1 CAPSULE in 1 BLISTER PACK (60687-591-11) | 20210106 | | No | Historical |
Related DailyMed Labels
| Set ID | Title | Manufacturer | Effective date | Type | Version |
|---|
| d4f21e97-5e55-44c9-9b31-5f79ac2eb512 | These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993 | Cardinal Health 107, LLC | 2026-01-12 | HUMAN PRESCRIPTION DRUG LABEL | 5 |
| bbfdedd7-2baf-4bc6-be59-548a5cf21752 | These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993 | American Health Packaging | 2025-10-03 | HUMAN PRESCRIPTION DRUG LABEL | 7 |
| d4f21e97-5e55-44c9-9b31-5f79ac2eb512 | These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993 | Cardinal Health 107, LLC | 2024-07-31 | HUMAN PRESCRIPTION DRUG LABEL | 3 |